Unlocking the Mystery: Data & Innovation in Women's Health

Vanessa Guzman has almost 20 years of experience leading and overseeing initiatives relating to Value-based Care Programs, including Centers for Medicare and Medicaid Services (CMS) Alternative Payment Models, Medicare Access, and CHIP Reauthorization Act (MACRA) Value-Based Payment models. 

She is a contributor in accountable care, digital health, data collection and reporting, quality improvement, and community-based related case studies and publications moderated by the National Committee for Quality Assurance (NCQA), Centers for Medicare and Medicaid Services (CMS), and The Office of the National Coordinator for Health Information Technology (ONC). She was named among Modern Healthcare’s Top Diversity Leaders in Healthcare – 2022. 

Sasha Ottey is the Founder and Executive Director of PCOS Challenge: The National Polycystic Ovary Syndrome Association. PCOS Challenge serves nearly 60,000 members and is the leading patient advocacy organization for people with PCOS. As Executive Director of PCOS Challenge, Sasha has had a significant global influence on PCOS awareness, education, advocacy, health policy and patient-focused drug development. 

Chief Business Officer, has decades of experience at the intersection of healthcare technology, data and AI, building and leading global teams in commercialization, business development and strategy, driving insights and developing solutions for life sciences companies. Previously, Wasserman served as Chief Revenue Officer for BrightInsight and Chief Commercial Officer with Genuity Science.

Cathy Zaremba is a mission-driven marketing leader with deep business acumen operating at the intersection of strategy, healthcare technology, and product marketing. Cathy brings to Medisafe a diverse background of healthcare experience, spanning both Fortune 100 Pharma (Abbott) as well as leading Healthcare IT firms (Wolters Kluwer Health) and startup digital health/ digital therapeutics companies like Welldoc and BrightInsight.